CIK 0001844417 · <br>Emerging growth company
Estrella Immunopharma, Inc.
Sign in to watch- Ticker
- ESLA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 861314502
- Phone
- (510) 318-9098
- Business address
- 5858 HORTON STREET, SUITE 370, EMERYVILLE, CA, 94608
- Former names
- TradeUP Acquisition Corp.
Securities
- ESLA Common Stock Nasdaq
- ESLAW Warrant Nasdaq
- 8-K Event Material agreement
- 10-Q Report Quarterly Report
- 8-K Event Auditor change
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K/A Event Bylaws or fiscal year change
- 8-K Event Material agreement · Acquisition or sale completed · New debt or obligation · Delisting notice · Unregistered share sale · Shareholder rights changed · Change in control · Executive or director change · Bylaws or fiscal year change · Code of ethics change · Shell status change
- 8-K Event Material agreement · Unregistered share sale
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Other events
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Other events
- 10-Q Report Quarterly Report
- 8-K Event Shareholder vote results · Other events
- 8-K Event Material agreement · Unregistered share sale
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Other events
- 8-K Event Material agreement · Bylaws or fiscal year change · Shareholder vote results · Other events
- 8-K Event Other events
- 8-K Event Delisting notice
- 8-K Event Material agreement
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
Page 3 of 5 · 85 filings